Online Learning > COVID-19 Resources > COVID-19 Webinar Series > Antibodies

Wednesday, July 22, 2020

Do’s and Don’ts of Antibody Testing: Policy and Practice

Update: Nepal in the Context of COVID-19

Johns Hopkins Center for Health Security Senior Scholar, Gigi Gronvall, will discuss the regulatory, policy, and scientific challenges in antibody testing for SARS-CoV-2.

Nepal is a majority rural country that sits between two giants: India and China. Nepal's unique geographical context and the current political climate has presented unique challenges in COVID response. Furthermore, there was an initial focus to push the serology test instead of the PCR, which led to protests across the country and confusion. Global Emergency Medicine Fellow at Brown University, Dr. Ramu Kharel, will discuss Nepal's context and its response to COVID thus far.





Do's and Dont's of Antibody Testing: Policy and Practice


Gigi Kwik Gronvall, PhD
Senior Scholar, Johns Hopkins Center for Health Security,
Associate Professor, Johns Hopkins Bloomberg School of Public Health,
Baltimore, MD


Update: Nepal in the Context of COVID-19


Ramu Kharel, MD, MPH
Founder, Health Advancement Programs to Serve All (HAPSA);
Global Emergency Medicine Fellow, Department of Emergency Medicine,
Brown University, Providence, RI



Series Partners

American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Academy of Emergency Nurse Practitioners (AAENP) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | Emergency Nurses Association (ENA) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)